IP Library › Granted Patent US 10,113,168
Granted Patent B2
US 10,113,168 · App. 15/209,422 · Granted Oct 30, 2018

Ribozyme with tRNA synthetase activity and methods of manufacturing and using the same

Inventors: Barbara L. Golden (West Lafayette, IN); Ji Chen (West Lafayette, IN); Andrej Luptak (Irvine, CA)
Assignees: Purdue Reasearch Foundation; The Regents of the University of California
C12N15/113C12P19/34C12P21/00C12N2310/12C12N2310/128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,113,168
App. No.
15/209,422
Granted
Oct 30, 2018
Kind
B2
Abstract

Ribozymes exhibiting tRNA synthetase activity and substrate specificity, as well as methods for engineering and producing the same, are disclosed. The ribozymes of the present disclosure comprise a T-box RNA module fused with a flexizyme module. The flexizyme module provides high promiscuity with respect to amino acid substrates and the T-box module provides tRNA substrate specificity. Systems are also described for aminoacylation of suppressor tRNAs with unnatural amino acids (uAAs), such systems comprising the ribozyme previously mentioned, suppressor tRNA, and the desired uAAs. Methods for incorporating a uAA into a growing polypeptide chain using the ribozyme hereof are also provided.

Claims (8)

1. An artificial ribozyme comprising:

a T-box element comprising a 3′-terminus and a riboswitch element having a specifier loop for binding a cognate tRNA substrate with specificity; and

a flexizyme comprising SEQ ID NO: 2, which defines at least an active site for binding an unnatural amino acid, an acceptor end for base pairing to a terminus of a tRNA substrate, a nucleotide linker, and a P1 stem linked to the 3′-terminus of the T-box element,

wherein when the T-box element recognizes and preferentially binds the cognate tRNA substrate, the flexizyme can bind and aminoacylate the cognate tRNA substrate bound by the T-box element, and the active site of the flexizyme is not specific to a targeted unnatural amino acid.

2. The artificial ribozyme of claim 1 , wherein the T-box element comprises a bacterial T-box element derived from a Geobacillus kaustophilus and the flexizyme comprises a dinitro-flexizyme.

3. The artificial ribozyme of claim 1 , wherein the 3′-terminus of the T-box element and a 5′-terminus of the flexizyme are connected via a poly-A linker comprising between five and ten nucleotides.

4. The artificial ribozyme of claim 3 , comprising SEQ ID NO: 1.

5. The artificial ribozyme of claim 1 , wherein a 5′-terminus of the T-box element further comprises a guanine-adenine-guanine nucleotide sequence linked thereto to facilitate in vitro transcription of the artificial ribozyme.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2018
From: GOLDEN, BARBARA; CHEN, JI
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 045847/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2018
From: LUPTAK, ANDREJ
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 046199/0411 →
Continuity (2)
Provisional Application 62166680 · May 27, 2015
Related Publication 20160348108A1 · Dec 1, 2016
Cited By (3)
US 1,134,933 US 12,448,618 US 12,492,394